Controls Over Compound Drugs at the Defense Health Agency Reduced Costs Substantially, but Improvements Are Needed

Submitting OIG:

Department of Defense OIG

Date Issued:

Friday, July 1, 2016

Agency Reviewed / Investigated:

Department of Defense

Submitting OIG-Specific Report Number:

DODIG-2016-105

Location(s):

United States

Type of Report:

Audit

Questioned Costs:

$99,469

Funds for Better Use:

Number of Recommendations:

View Document:

Attachment	Size
DODIG-2016-105.pdf	3.59 MB

Related Open Recommendations

No Recommendations found for this Report.

Department of Defense OIG

Department of Defense

The Department of Defense Office of Inspector General was established in 1982. The mission of the DoD OIG, as established by the Inspector General Act of 1978, as amended, (5 U.S.C. Appendix); and implemented by DoD Directive 5106.01, "Inspector General of the Department of Defense," is to serve as an independent and objective office in DoD to:

a) conduct, supervise, monitor, and initiate audits, evaluations, and investigations relating to programs and operations of the Department of Defense,

b) provide leadership and coordination and recommend policies for activities designed to promote economy, efficiency, and effectiveness in the administration of, and to prevent and detect fraud and abuse in, such programs and operations,

c) provide a means for keeping the Secretary of Defense and the Congress fully and currently informed about problems and deficiencies relating to the administration of such programs and operations and the necessity for and progress of corrective action

http://www.dodig.mil

Search form

Controls Over Compound Drugs at the Defense Health Agency Reduced Costs Substantially, but Improvements Are Needed

Related Open Recommendations